• This record comes from PubMed

Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1

. 2015 Jul 14 ; 113 (2) : 321-6. [epub] 20150609

Language English Country Great Britain, England Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/pmid26057450

BACKGROUND: Tongue squamous cell carcinoma (TSCC) is increasing in incidence, especially among young patients and preferably females. Infection with human papilloma virus (HPV) has been suggested as a cause of SCC in the head and neck, and the proportion of oropharyngeal cancers caused by HPV has steadily increased. METHODS: Samples from 109 patients with primary TSCC were analysed for the presence of HPV16 by in situ hybridisation and for expression of its surrogate marker p16 and the HPV receptor syndecan-1 by immunhistochemistry. RESULTS: No evidence of HPV16 DNA was observed in the tumours, although one-third showed p16 staining. There was no difference in the expression of the primary HPV receptor, syndecan-1, between TSCC and a group of tonsil SCC. CONCLUSION: Whereas p16 is expressed in some TSCCs, HPV16 is undetectable, therefore, p16 cannot be used as a surrogate marker for high-risk HPV-infection in this tumour. Despite presence of the HPV-receptor syndecan-1 in TSCC, HPV prefers the tonsillar environment. Lack of p16 associates with worse prognosis primarily in patients aged ⩽40 years with tongue SCC. The improved prognosis seen in p16-positive TSCC can be due to induction of a senescent phenotype or an inherent radiosensitivity due to the ability of p16 to inhibit homologous recombination repair.

See more in PubMed

Boldrup L, Coates PJ, Laurell G, Nylander K. Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity. Oral Oncol. 2011;47:861–865. PubMed

Boldrup L, Coates PJ, Laurell G, Nylander K. p63 transcriptionally regulates BNC1, a Pol I and Pol II transcription factor that regulates ribosomal biogenesis and epithelial differentiation. Eur J Cancer. 2012;48 (9:1401–1406. PubMed

Bussu F, Sali M, Vellone VG, Zannoni GF, Autorino R, Dinapoli N, Santangelo R, Martucci R, Graziani C, Miccickè F, Almadori G, Galli J, Delogu G, Sanguinetti M, Rindi G, Valentini V, Paludetti G. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker. Br J Cancer. 2013;108:1157–1162. PubMed PMC

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29 (32:4294–4301. PubMed PMC

Coates PJ, Hall PA, Butler MG, d'Ardenne AJ. Rapid technique of DNA-DNA in situ hybridisation on formalin fixed tissue sections using microwave irradiation. J Clin Pathol. 1987;40 (8:865–869. PubMed PMC

Coates PJ, Slavin G, D'Ardenne AJ. Persistence of Epstein-Barr virus in Reed-Sternberg cells throughout the course of Hodgkin's disease. J Pathol. 1991;164 (4:291–297. PubMed

Detre S, Saccani Jotti G, Dowsett M. A ‘quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995;48:876–878. PubMed PMC

Dok R, Kalev P, van Limbergen EJ, Asbagh LA, Vázquez I, Hauben E, Sablina A, Nuyts S. p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors. Cancer Res. 2014;74:1739–1751. PubMed

Doxtader EE, Katzenstein ALA. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum Pathol. 2012;43:327–332. PubMed

Gröbe A, Hanken H, Kluwe L, Schöllchen M, Tribius S, Pohlenz P, Clauditz T, Grob T, Simon R, Sauter G, Heiland M, Blessmann M. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma. J Oral Pathol Med. 2013;42 (9:676–681. PubMed

Harris SL, Thorne LB, Seaman WT, Hayes DN, Couch ME, Kimple RJ. Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head and Neck. 2011;33:1622–1627. PubMed

Herrington CS, Graham AK, McGee JO. Interphase cytogenetics using biotin and digoxigenin labelled probes: III. Increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines. J Clin Pathol. 1991;44 (1:33–38. PubMed PMC

Hilly O, Shkedy Y, Hod R, Soudry E, Mizrachi A, Hamzany Y, Bachar G, Shpitzer T. Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years. Oral Oncol. 2013;49 (10:987–990. PubMed

Hoffmann M, Tribius S, Quabius ES, Henry H, Pfannenschmidt S, Burkhardt C, Görögh T, Halec G, Hoffmann AS, Kahn T, Röcken C, Haag J, Waterboer T, Schmitt M. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer—how valid is p16INK4A as surrogate marker. Cancer Lett. 2012;323:88–96. PubMed

Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012;36 (7:945–954. PubMed PMC

Li J, Poi MJ, Tsai MD. Regulatory mechanisms of tumor suppressor P16INK4A and their relevance to cancer. Biochemistry. 2011;50:5566–5582. PubMed PMC

Loizou C, Laurell G, Lindquist D, Öfverman C, Stefansson K, Nylander K, Olofsson K.2015Incidence of tonsillar cancer in northern Sweden: impact of human papilloma virus Oncol Lett http://dx.doi.org/10.3109/00016489.2015.1048378 . PubMed DOI PMC

Lundqvist L, Stenlund H, Laurell G, Nylander K. The importance of stromal inflammation in squamous cell carcinoma of the tongue. J Oral Pathol Med. 2012;41 (5:379–383. PubMed

Marur S, D́Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781–789. PubMed PMC

Migaldi M, Pecorari M, Forbicini G, Nanni N, Grottola A, Grandi T, Delle Donne G, Leocata P, Trovato D, Sgambato A. Low prevalence of human papillomavirus infection in the healthy oral mucosa of a northern Italian population. J Oral Path Med. 2012;41:16–20. PubMed

Pannone G, Santoro A, Carinci F, Bufo P, Papagerakis SM, Rubini C, Campisi G, Giovanelli L, Contaldo M, Serpico R, Mazzotta M, Lo Muzio L. Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers. Int J Immunpathol Pharmacol. 2011;24 (2S:95–101. PubMed

Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, Hackman T, Hayes DN, Shores C, Chera BS. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011;29:1488–1494. PubMed

Pickering CR, Zhang J, Neskey DM, Zhao M, Jasser SA, Wang J, Ward A, Tsai CJ, Ortega Alves MV, Zhou JH, Drummond J, El-Naggar AK, Gibbs R, Weinstein JN, Wheeler DA, Wang J, Frederick MJ, Myers JN. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin Cancer Res. 2014;20 (14:3842–3848. PubMed PMC

Rautava J, Syrjänen S. Biology of human papillomavirus infections in head and neck carcinogenesis. Head Neck Pathol. 2012;6:S3–S15. PubMed PMC

Rieckmann T, Tribius S, Grob TJ, Meyer F, Busch CJ, Petersen C, Dikomey E, Kriegs M. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol. 2013;107:242–246. PubMed

Rietbergen MM, Braakhuis BJM, Moukhtari N, Bloemena E, Bring A, Sie D, Ylstra B, Baatenburg de Jong RJ, Snijders PJF, Brakenhoff RH, Leemans CR. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumours. J Oral Pathol Med. 2014;43:137–142. PubMed

Romagosa C, Simonetti S, Lòpez-Vicente L, Mazo A, Lleonart ME, Castellvi J, Cajal SR. p16INK4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene. 2011;30:2087–2097. PubMed

Sand L, Jalouli J. Viruses and oral cancer. Is there a link. Microbes Infect. 2014;16:371–378. PubMed

Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Modern Pathol. 2011;24 (10:1295–1305. PubMed PMC

Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, Shah PM, Verma RJ. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck. 2009;31:1544–1556. PubMed

Shafti-Keramat S, Handisurya A, Kriehuber E, Meneguzzi G, Slupetzky K, Kirnbauer R. Different heparin sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol. 2003;77 (24:13125–13135. PubMed PMC

Syrjanen S, Lodi G, von Bultzingslowen I, Aliko A, Arduino A, Campisi G, Challacombe S, Ficarra G, Flaitz C, Zhou HM, Maeda H, Miller C, Jontell M. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17 (Suppl. 1:58–72. PubMed

Troeltzsch M, Knösel T, Eichinger C, Probst F, Troeltzsch M, Woodlock T, Mast G, Ehrenfeld M, Otto S. Clinicopathologic features of oral squamous cell carcinoma: do they vary in different age groups. J Oral Maxillofac Surg. 2014;72 (7:1291–1300. PubMed

Witkiewicz AK, Knudsen KE, Picker AP, Knudsen ES. The meaning of p16ink4a expression in tumor. Functional significance, clinical associations and future developments. Cell Cycle. 2011;10 (15:2497–2503. PubMed PMC

Find record

Citation metrics

Archiving options